Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Astellas Pharma

Donald B. Rice, Ph.D. will retire from Agensys, Inc., an affiliate of Astellas Pharma, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Donald B. Rice, Ph.D. will retire from Agensys, Inc., an affiliate of Astellas Pharma, Inc. Sef Kurstjens, M.D., Ph.D. will replace Dr. Rice as the new chief executive officer and president. Founded by Dr. Rice, Agensys, Inc. develops novel oncology products through its pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers.

Dr. Kurstjens joins the company from Allergan, Inc., where he served as senior vice president, chief medical officer and head, Global Drug Development. Dr. Kurstjens has leadership experience in all aspects of clinical development and will lead the company in its efforts to improve patients’ lives through a growing pipeline of clinical stage functional MAbs and antibody-drug conjugated products.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics